Compare KRYS & CLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRYS | CLF |
|---|---|---|
| Founded | 2015 | 1847 |
| Country | United States | United States |
| Employees | N/A | 25000 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 7.5B |
| IPO Year | 2017 | 2006 |
| Metric | KRYS | CLF |
|---|---|---|
| Price | $305.25 | $13.11 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 13 |
| Target Price | ★ $388.22 | $14.35 |
| AVG Volume (30 Days) | 296.5K | ★ 23.9M |
| Earning Date | 11-02-2026 | 10-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 128.00 | N/A |
| EPS | ★ 5.66 | N/A |
| Revenue | $389,130,000.00 | ★ $18,610,000,000.00 |
| Revenue This Year | $27.84 | $15.11 |
| Revenue Next Year | $27.62 | $8.17 |
| P/E Ratio | $54.71 | ★ N/A |
| Revenue Growth | ★ 33.94 | N/A |
| 52 Week Low | $198.02 | $7.73 |
| 52 Week High | $382.54 | $15.35 |
| Indicator | KRYS | CLF |
|---|---|---|
| Relative Strength Index (RSI) | 43.87 | 52.63 |
| Support Level | $284.16 | $10.56 |
| Resistance Level | $317.53 | $14.73 |
| Average True Range (ATR) | 11.47 | 0.85 |
| MACD | 0.01 | -0.11 |
| Stochastic Oscillator | 49.77 | 53.04 |
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
Cleveland-Cliffs Inc is a flat-rolled steel producer and manufacturer of iron ore pellets in North America. It is organized into four operating segments based on differentiated products, Steelmaking, Tubular, Tooling and Stamping and European Operations, but operates through one reportable segment -Steelmaking. It is vertically integrated from mined raw materials, direct reduced iron, and ferrous scrap to primary steelmaking and downstream finishing, stamping, tooling and tubing. It serves a diverse range of other markets due to its comprehensive offering of flat-rolled steel products. Geographically, it operates in the United States, Canada and other countries. The majority of revenue is from the United States. It is a supplier of steel to the automotive industry in North America.